- Escin’s Multifaceted Therapeutic Profile in Treatment and Post-Treatment of Various Cancers: A Comprehensive Review
Sunnatullo Fazliev et al, 2023, Biomolecules CrossRef - Roles of the CXCL8-CXCR1/2 Axis in the Tumor Microenvironment and Immunotherapy
Zhi-Jian Han et al, 2021, Molecules CrossRef - Natural products targeting tumour angiogenesis
Xiaohua Lu et al, 2023, British Journal of Pharmacology CrossRef - Cytokines: Can Cancer Get the Message?
Rachel M. Morris et al, 2022, Cancers CrossRef - Enhanced mitochondrial co-localization of β-escin micelle and pancreatic tumor accumulation relation
Burcu Uner et al, 2023, Journal of Drug Delivery Science and Technology CrossRef - The Role of Signaling Pathways in Pancreatic Cancer Targeted Therapy
Fangfang Zhuo et al, 2023, American Journal of Clinical Oncology CrossRef - Escin enhanced the efficacy of sorafenib by autophagy‐mediated apoptosis in lung cancer cells
Yusuf Hussain et al, 2023, Phytotherapy Research CrossRef - Girdin regulates both migration and angiogenesis in pancreatic cancer cell lines
Yuichi Hayashi et al, 2023, Oncology Reports CrossRef - 10Z‑Hymenialdisine inhibits angiogenesis by suppressing NF‑κB activation in pancreatic cancer cell lines
Goro Ueda et al, 2022, Oncology Reports CrossRef - Clinical diagnosis and management of pancreatic cancer: Markers, molecular mechanisms, and treatment options
Chun-Ye Zhang et al, 2022, World Journal of Gastroenterology CrossRef - Crosstalk of Inflammatory Cytokines within the Breast Tumor Microenvironment
Ola Habanjar et al, 2023, International Journal of Molecular Sciences CrossRef - Role of Escin in breast cancer therapy: potential mechanism for inducing ferroptosis and synergistic antitumor activity with cisplatin
Chenyuan Li et al, 2023, Apoptosis CrossRef - The Natural Product Parthenolide Inhibits Both Angiogenesis and Invasiveness and Improves Gemcitabine Resistance by Suppressing Nuclear Factor κB Activation in Pancreatic Cancer Cell Lines
Yuki Denda et al, 2024, Nutrients CrossRef - β-Escin reduces cancer progression in aggressive MDA-MB-231 cells by inhibiting glutamine metabolism through downregulation of c-myc oncogene
Sakine AKAR et al, 2022, Molecular Biology Reports CrossRef